These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
462 related items for PubMed ID: 17045636
61. Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease. Geerts H, Grossberg GT. J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):8S-16S. PubMed ID: 16809810 [Abstract] [Full Text] [Related]
62. Dynamin 1 depletion and memory deficits in rats treated with Abeta and cerebral ischemia. Watanabe T, Iwasaki K, Takasaki K, Yamagata N, Fujino M, Nogami A, Ii M, Katsurabayashi S, Mishima K, Fujiwara M. J Neurosci Res; 2010 Jul; 88(9):1908-17. PubMed ID: 20127811 [Abstract] [Full Text] [Related]
63. [Changes of NMDA receptor expression in rat hippocampal formation after establishment of spatial memory by different training modes]. Zhang L, Yu W, Han TZ, Xie W, Luo Y. Sheng Li Xue Bao; 2006 Oct 25; 58(5):442-8. PubMed ID: 17041728 [Abstract] [Full Text] [Related]
64. [A comparative study of the central H-cholinergic-blocking and NMDA-blocking actions of MK-801, memantin, amantadine, pyrilen and IEM-1754 in experiments on intact rats]. Gmiro VE, Serdiuk SE. Eksp Klin Farmakol; 2000 Oct 25; 63(2):16-20. PubMed ID: 10834088 [Abstract] [Full Text] [Related]
65. A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats. Manahan-Vaughan D, von Haebler D, Winter C, Juckel G, Heinemann U. Hippocampus; 2008 Oct 25; 18(2):125-34. PubMed ID: 17924525 [Abstract] [Full Text] [Related]
66. Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils. Lorrio S, Negredo P, Roda JM, García AG, López MG. Brain Res; 2009 Feb 13; 1254():128-37. PubMed ID: 19103181 [Abstract] [Full Text] [Related]
67. Idazoxan blocks the nicotine-induced reversal of the memory impairment caused by the NMDA glutamate receptor antagonist dizocilpine. Timofeeva OA, Levin ED. Pharmacol Biochem Behav; 2008 Sep 13; 90(3):372-81. PubMed ID: 18456310 [Abstract] [Full Text] [Related]
68. Subchronic memantine administration on spatial learning, exploratory activity, and nest-building in an APP/PS1 mouse model of Alzheimer's disease. Filali M, Lalonde R, Rivest S. Neuropharmacology; 2011 May 13; 60(6):930-6. PubMed ID: 21281652 [Abstract] [Full Text] [Related]
69. [Protective effect of memantine on N-methyl-D-aspartate receptor in dichlorvos-poisoned rat brain]. Dai XF, Zhou ZJ, Gu XA, Sun YG, Zheng G, Zheng J. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Feb 13; 22(1):11-4. PubMed ID: 15033007 [Abstract] [Full Text] [Related]
70. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Lipton SA. Nat Rev Drug Discov; 2006 Feb 13; 5(2):160-70. PubMed ID: 16424917 [Abstract] [Full Text] [Related]
71. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine. Riepe MW, Adler G, Ibach B, Weinkauf B, Tracik F, Gunay I. Dement Geriatr Cogn Disord; 2007 Feb 13; 23(5):301-6. PubMed ID: 17356273 [Abstract] [Full Text] [Related]
72. Bis(7)-tacrine prevents glutamate-induced excitotoxicity more potently than memantine by selectively inhibiting NMDA receptors. Liu YW, Li CY, Luo JL, Li WM, Fu HJ, Lao YZ, Liu LJ, Pang YP, Chang DC, Li ZW, Peoples RW, Ai YX, Han YF. Biochem Biophys Res Commun; 2008 May 16; 369(4):1007-11. PubMed ID: 18328812 [Abstract] [Full Text] [Related]
73. Effects of NMDA receptor antagonists on visceromotor reflexes and on intestinal motility, in vivo. Shafton AD, Bogeski G, Kitchener PD, Sanger GJ, Furness JB, Shimizu Y. Neurogastroenterol Motil; 2007 Jul 16; 19(7):617-24. PubMed ID: 17539896 [Abstract] [Full Text] [Related]
75. Effects of sub-anesthetic doses of ketamine on rats' spatial and non-spatial recognition memory. Pitsikas N, Boultadakis A, Sakellaridis N. Neuroscience; 2008 Jun 23; 154(2):454-60. PubMed ID: 18472348 [Abstract] [Full Text] [Related]
76. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors. Gilling KE, Jatzke C, Hechenberger M, Parsons CG. Neuropharmacology; 2009 Apr 23; 56(5):866-75. PubMed ID: 19371579 [Abstract] [Full Text] [Related]
77. Late phase of long-term potentiation induced by co-application of N-methyl-d-aspartic acid and the antagonist of NR2B-containing N-methyl-d-aspartic acid receptors in rat hippocampus. Oh-Nishi A, Saji M, Satoh SZ, Ogata M, Suzuki N. Neuroscience; 2009 Mar 03; 159(1):127-35. PubMed ID: 19010396 [Abstract] [Full Text] [Related]
78. [Role of magnesium ions on the regulation of NMDA receptor--a pharmacopathology of memantine]. Kato T. Clin Calcium; 2004 Aug 03; 14(8):76-80. PubMed ID: 15577101 [Abstract] [Full Text] [Related]